Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig D Shriver

Showing results (241-250 of 293) with videos related to

Pageof 30
Sort By:
Cancer Growth and Metastasis|August 18, 2015
Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting AnalysisRachel E Ellsworth, Allyson L Toro, Heather L Blackburn, et al.
Experimental Cell Research|December 3, 2014
Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growthJoji Iida, Jesse Dorchak, Rebecca Clancy, et al.
Military Medicine|July 18, 2025
Superior Survival Outcomes of Epithelial Ovarian Cancer Patients in the Universal Access Military Healthcare System Compared With the National Surveillance, Epidemiology, and End Results ProgramKathleen M Darcy, Christopher M Tarney, Aimee B Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patientsZia A Dehqanzada, Catherine E Storrer, Matthew T Hueman, et al.
Breast Cancer Research and Treatment|February 24, 2006
Prospective study of electrical impedance scanning for identifying young women at risk for breast cancerAlexander Stojadinovic, Orah Moskovitz, Zahava Gallimidi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Electrical impedance scanning for the early detection of breast cancer in young women: preliminary results of a multicenter prospective clinical trialAlexander Stojadinovic, Aviram Nissan, Zahava Gallimidi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2016
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platformsAmy R Peck, Melanie A Girondo, Chengbao Liu, et al.
Journal of Clinical Immunology|May 28, 2004
Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patientsMichael M Woll, Christine M Fisher, Gayle B Ryan, et al.
Communications Medicine|July 24, 2025
Simultaneous expression of epithelial and immune cell markers in circulating tumor cells identified in patients with stage 4 breast cancerNikki Higa, Audrey Limb, Valerie Hennes, et al.
Gynecologic Oncology|January 20, 2020
Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilitiesJennifer Vaz, Chunqiao Tian, Michael T Richardson, et al.
Pageof 30

Showing results (241-250 of 293) with videos related to

Sort By:
Pageof 30
Cancer Growth and Metastasis|August 18, 2015
Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting AnalysisRachel E Ellsworth, Allyson L Toro, Heather L Blackburn, et al.
Experimental Cell Research|December 3, 2014
Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growthJoji Iida, Jesse Dorchak, Rebecca Clancy, et al.
Military Medicine|July 18, 2025
Superior Survival Outcomes of Epithelial Ovarian Cancer Patients in the Universal Access Military Healthcare System Compared With the National Surveillance, Epidemiology, and End Results ProgramKathleen M Darcy, Christopher M Tarney, Aimee B Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patientsZia A Dehqanzada, Catherine E Storrer, Matthew T Hueman, et al.
Breast Cancer Research and Treatment|February 24, 2006
Prospective study of electrical impedance scanning for identifying young women at risk for breast cancerAlexander Stojadinovic, Orah Moskovitz, Zahava Gallimidi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Electrical impedance scanning for the early detection of breast cancer in young women: preliminary results of a multicenter prospective clinical trialAlexander Stojadinovic, Aviram Nissan, Zahava Gallimidi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2016
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platformsAmy R Peck, Melanie A Girondo, Chengbao Liu, et al.
Journal of Clinical Immunology|May 28, 2004
Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patientsMichael M Woll, Christine M Fisher, Gayle B Ryan, et al.
Communications Medicine|July 24, 2025
Simultaneous expression of epithelial and immune cell markers in circulating tumor cells identified in patients with stage 4 breast cancerNikki Higa, Audrey Limb, Valerie Hennes, et al.
Gynecologic Oncology|January 20, 2020
Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilitiesJennifer Vaz, Chunqiao Tian, Michael T Richardson, et al.
Pageof 30